U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219199) titled 'Residual IDH1-Mutant Tumor Cell Quantification Study' on Oct. 20.
Brief Summary: This is a single-site, single-arm, prospective, interventional cohort study using intraoperative ultra-rapid droplet digital polymerase chain reaction (UR- ddPCR) to assess residual IDH1-mutant tumor at the end of surgical resection and, if positive, guide additional resection in real-time.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Glioma
Intervention:
DEVICE: UR-ddPCR
The investigational UR-ddPCR assay will be performed on collected tissue specimens during the participant's scheduled surgical visit.
Recruitment Status: ...